396 related articles for article (PubMed ID: 9727762)
1. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma.
Reijonen TM; Korppi M
Pediatr Pulmonol; 1998 Aug; 26(2):113-9. PubMed ID: 9727762
[TBL] [Abstract][Full Text] [Related]
2. Predictors of asthma three years after hospital admission for wheezing in infancy.
Reijonen TM; Kotaniemi-Syrjänen A; Korhonen K; Korppi M
Pediatrics; 2000 Dec; 106(6):1406-12. PubMed ID: 11099596
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory therapy reduces wheezing after bronchiolitis.
Reijonen T; Korppi M; Kuikka L; Remes K
Arch Pediatr Adolesc Med; 1996 May; 150(5):512-7. PubMed ID: 8620234
[TBL] [Abstract][Full Text] [Related]
4. Sodium cromoglycate therapy in wheezing infants: preliminary evidence of beneficial outcome at early school age.
Kotaniemi-Syrjänen A; Reijonen TM; Korhonen K; Korppi M
Pediatr Int; 2005 Dec; 47(6):627-34. PubMed ID: 16354214
[TBL] [Abstract][Full Text] [Related]
5. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis.
Reijonen TM; Korppi M; Kuikka L; Savolainen K; Kleemola M; Mononen I; Remes K
Pediatr Pulmonol; 1997 Jun; 23(6):397-403. PubMed ID: 9220520
[TBL] [Abstract][Full Text] [Related]
6. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood.
Prehn A; Seger RA; Torresani T; Molinari L; Sennhauser FH
Pediatr Allergy Immunol; 2000 May; 11(2):87-94. PubMed ID: 10893010
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for asthma symptoms at school age: an 8-year prospective study.
Morais-Almeida M; Gaspar A; Pires G; Prates S; Rosado-Pinto J
Allergy Asthma Proc; 2007; 28(2):183-9. PubMed ID: 17479602
[TBL] [Abstract][Full Text] [Related]
9. Does blood eosinophilia in wheezing infants predict later asthma? A prospective 18-20-year follow-up.
Piippo-Savolainen E; Remes S; Korppi M
Allergy Asthma Proc; 2007; 28(2):163-9. PubMed ID: 17479599
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal eosinophil cationic protein in bronchiolitis: relation to viral findings and subsequent wheezing.
Reijonen TM; Korppi M; Kleemola M; Savolainen K; Kuikka L; Mononen I; Remes K
Pediatr Pulmonol; 1997 Jul; 24(1):35-41. PubMed ID: 9261851
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory pharmacotherapy for wheezing in preschool children.
Kaditis AG; Winnie G; Syrogiannopoulos GA
Pediatr Pulmonol; 2007 May; 42(5):407-20. PubMed ID: 17358042
[TBL] [Abstract][Full Text] [Related]
12. Inhaled steroids compared with disodium cromoglycate in preschool children with episodic viral wheeze.
De Baets F; Van Daele S; Franckx H; Vinaimont F
Pediatr Pulmonol; 1998 Jun; 25(6):361-6. PubMed ID: 9671161
[TBL] [Abstract][Full Text] [Related]
13. Response to budesonide among atopic and non-atopic infants/preschoolers with recurrent wheezing.
Campusano L; Pastenes M; Fontecilla C; Escalona J; Salazar C; Castro-Rodriguez JA
Allergol Immunopathol (Madr); 2010; 38(1):31-6. PubMed ID: 19875223
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
McLaughlin T; Leibman C; Patel P; Camargo CA
Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
[TBL] [Abstract][Full Text] [Related]
15. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes.
Volovitz B; Soferman R; Blau H; Nussinovitch M; Varsano I
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):464-9. PubMed ID: 9564798
[TBL] [Abstract][Full Text] [Related]
16. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
Leflein JG; Szefler SJ; Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Smith JA
Pediatrics; 2002 May; 109(5):866-72. PubMed ID: 11986448
[TBL] [Abstract][Full Text] [Related]
17. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age.
Arshad SH; Kurukulaaratchy RJ; Fenn M; Matthews S
Chest; 2005 Feb; 127(2):502-8. PubMed ID: 15705988
[TBL] [Abstract][Full Text] [Related]
18. Successful withdrawal of inhaled corticosteroids in childhood asthma.
Perera BJ
Respirology; 2005 Jun; 10(3):385-8. PubMed ID: 15955154
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil counts and urinary eosinophil protein X in children hospitalized for wheezing during the first year of life: prediction of recurrent wheezing.
Oymar K; Havnen J; Halvorsen T; Bjerknes R
Acta Paediatr; 2001 Aug; 90(8):843-9. PubMed ID: 11529528
[TBL] [Abstract][Full Text] [Related]
20. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy.
Remes S; Korppi M; Remes K; Savolainen K; Mononen I; Pekkanen J
Pediatr Pulmonol; 1998 Mar; 25(3):167-74. PubMed ID: 9556008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
